Caelus Pharmaceuticals B.V. – Trademark Portfolio
Entity Type: 98
Caelus Pharmaceuticals B.V. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include GLUCOBIOME, CAELUS HEALTH, and G GLUCOCHANGE.
Rondweg 50
Zegveld NL-3474 KG
Showing of trademarks Trademarks
Trademark Classifications
Caelus Pharmaceuticals B.V.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Caelus Pharmaceuticals B.V. have?
Caelus Pharmaceuticals B.V. has 9 U.S. trademarks filed with the USPTO. Of these, 3 registered, 5 abandoned.
What trademark classes does Caelus Pharmaceuticals B.V. file in?
Caelus Pharmaceuticals B.V. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Caelus Pharmaceuticals B.V.'s most well-known trademarks?
Caelus Pharmaceuticals B.V.'s registered trademark portfolio includes well-known marks such as GLUCOBIOME, CAELUS HEALTH, and G GLUCOCHANGE. These are among 3 currently registered trademarks in the portfolio.
What is Caelus Pharmaceuticals B.V.'s trademark registration success rate?
Caelus Pharmaceuticals B.V. has a 38% trademark registration rate, with 3 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.